Grace Edmunds

Dr. Grace Edmunds

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2021 in Canine Medicine and Genetics
Verified
Journal Article
Open access
PDF file
GEGrace Edmunds
Grace Edmunds
MSMatthew J. Smalley
Matthew J. Smalley
SBSam Beck
Sam Beck
RERachel J. Errington
Rachel J. Errington
SGSara Gould
Sara Gould
DODan Gerard O'Neill
Dan Gerard O'Neill
Background: Osteosarcoma is an aggressive and painful bone neoplasm in dogs. Previous studies have reported epidemiological associations suggesting that large body mass, long bone length and the genetics of certain breeds including the Rottweiler are associated with elevated osteosarcoma risk. However, these studies were often limited by selection bias and confounding factors, and have rarely offered insights into breed-associated protection for osteosarcoma. The current study includes 1756 appendicular and axial osteosarcoma cases presenting to VPG Histology (Bristol, UK) compared against a control population of 905,211 dogs without osteosarcoma from primary care electronic patient records in the VetCompass™ dataset.Methods and study design: Retrospective, case-control study. Multivariable logistic regression analysis explored associations between demographic risk factors (including breed, chondrodystrophy, age, sex/neuter status, skull-shape, and body mass) and osteosarcoma of all anatomical sites.Results: We identified several breeds with increased and reduced odds of osteosarcoma. At highest risk were the Rottweiler and Great Dane, with > 10 times the odds of osteosarcoma compared with crossbreds, and the Rhodesian Ridgeback, which has not featured in previous lists of at-risk breeds for osteosarcoma, and had an odds ratio of 11.31 (95% confidence interval 7.37–17.35). Breeds at lowest risk of osteosarcoma (protected breeds) included the Bichon Frise, the French Bulldog and the Cavalier King Charles Spaniel, all with odd ratios of less than 0.30 compared with crossbreds. Body mass was strongly associated with osteosarcoma risk; dogs over 40 kg exhibited osteosarcoma odds of 45.44 (95% confidence interval 33.74–61.20) compared with dogs less than 10 kg. Chondrodystrophic breeds had an osteosarcoma odds ratio of 0.13 (95% confidence interval 0.11–0.16) compared with non-chondrodystrophic breeds.Conclusions: This study provides evidence of strong breed-associated osteosarcoma risk and protection, suggesting a genetic basis for osteosarcoma pathogenesis. It highlights that breeds selected for long legs/large body mass are generally overrepresented amongst at-risk breeds, whilst those selected for short leg length/small body mass are generally protected. These findings could inform genetic studies to identify osteosarcoma risk alleles in canines and humans; as well as increasing awareness amongst veterinarians and owners, resulting in improved breeding practices and clinical management of osteosarcoma in dogs.

27 June 2023 in Canine Medicine and Genetics
Verified
Journal Article
Open access
PDF file
DODan Gerard O'Neill
Dan Gerard O'Neill
GEGrace Edmunds
Grace Edmunds
JUJade Urquhart-Gilmore
Jade Urquhart-Gilmore
DCDavid. Church
David. Church
LRLynda Rutherford
Lynda Rutherford
DBDave C. Brodbelt
Dave C. Brodbelt
Background: Osteosarcoma is a malignant bone neoplasia that has high welfare consequences for affected dogs. Awareness of breed and canine conformational risk factors for osteosarcoma can assist with earlier diagnosis and improved clinical management. Study of osteosarcoma in dogs also offers translational value for humans. Anonymised clinical data within VetCompass on dogs under primary veterinary care in the UK were searched for osteosarcoma cases. Descriptive statistics reported overall and breed-specific prevalence. Risk factor analysis used multivariable logistic regression modelling. Results: From 905,552 study dogs, 331 osteosarcoma cases were confirmed yielding a one-year period prevalence of 0.037% (95% CI: 0.033–0.041). Breeds with the highest annual prevalence were the Scottish Deerhound (3.28%, 95% CI 0.90–8.18), Leonberger (1.48%, 95% CI 0.41- 3.75), Great Dane (0.87%, 95% CI 0.43- 1.55) and Rottweiler (0.84%, 95% CI 0.64–1.07). The median age at diagnosis was 9.64 years (IQR: 7.97–11.41). Following multivariable modelling, 11 breeds showed increased odds of osteosarcoma compared with crossbred dogs. Breeds with the highest odds included Scottish Deerhound (OR 118.40, 95% CI 41.12–340.95), Leonberger (OR 55.79, 95% CI 19.68–158.15), Great Dane (OR 34.24, 95% CI 17.81–65.83) and Rottweiler (OR 26.67, 95% CI 18.57–38.29). Compared with breeds with mesocephalic skull conformation, breeds with dolichocephalic skull conformation (OR 2.72, 95% CI 2.06–3.58) had increased odds while breeds with brachycephalic skull conformation showed reduced odds (OR 0.50, 95% CI 0.32–0.80). Chondrodystrophic breeds had 0.10 times the odds (95% CI 0.06–0.15) compared with non-chondrodystrophic breeds. Increasing adult bodyweight was associated with increasing odds of osteosarcoma. Conclusions: The current study cements the concept that breed, bodyweight and longer leg or longer skull length are all strong risk factors for osteosarcoma in dogs. With this awareness, veterinarians can update their clinical suspicion and judgement, breeders can select towards lower-risk animals, and researchers can robustly define more useful study populations for fundamental and translational bioscience.

15 September 2020 in Science Signaling
Verified
Journal Article
Closed access
RARachel Ambler
Rachel Ambler
GEGrace Edmunds
Grace Edmunds
STSin Lih Tan
Sin Lih Tan
SCSilvia Cirillo
Silvia Cirillo
JPJane I. Pernes
Jane I. Pernes
CWChristoph Wulfing
Christoph Wulfing
PD-1 signaling suppresses tumor-infiltrating lymphocytes by destabilizing their interactions with target tumor cells.

23 September 2025 in Science Signaling
Verified
Journal Article
Closed access
HAHanin Alamir
Hanin Alamir
CWCarissa C. W. Wong
Carissa C. W. Wong
AAAmal Alsubaiti
Amal Alsubaiti
GEGrace Edmunds
Grace Edmunds
MAMaryam Alismail
Maryam Alismail
CWChristoph Wulfing
Christoph Wulfing
TIM3 is a coregulatory receptor that is highly abundant on multiple immune cell types, including T cells in response to prolonged exposure to antigen, and it marks functionally suppressed cytotoxic T lymphocytes (CTLs) in the tumor microenvironment. TIM3 exhibits inhibitory function in vivo but paradoxically has costimulatory T cell signaling capability in vitro. Here, we found that TIM3 directly inhibited the function of murine and human CTLs in direct interaction with target tumor cell spheroids. TIM3 regulated the ability of suppressed CTLs to polarize their actin cytoskeleton as a required step in cytolysis. Whereas the expression of the proposed TIM3 ligands CEACAM1 and galectin 9 in trans on target tumor cells enhanced TIM3 function, expression of CEACAM1 in cis on CTLs had the opposite effect. TIM3 functioned as an inhibitory receptor on spheroid-suppressed CTLs but not on active CTLs in a two-dimensional tissue culture model. Together, these data suggest that TIM3 enhances T cell function, serving as either a coinhibitory or costimulatory receptor depending on the functional context of the T cell on which it is expressed.

14 October 2020 in Research Square
Verified
Preprint
Open access
PDF file
GEGrace Edmunds
Grace Edmunds
MSMatthew J Smalley
Matthew J Smalley
SBSam Beck
Sam Beck
RERachel J Errington
Rachel J Errington
SGSara Gould
Sara Gould
DODan G O'Neill
Dan G O'Neill
BackgroundOsteosarcoma is an aggressive and painful bone neoplasm in dogs. Previous studies have reported epidemiological associations suggesting that large body mass, long bone length and the genetics of certain breeds including the Rottweiler are associated with elevated osteosarcoma risk. However, these studies were often limited by selection bias and confounding, and have rarely offered insights into breed-associated protection as well as breed-associated predisposition for osteosarcoma. The current study includes 1756 osteosarcoma cases presenting to VPG Histology (Bristol, UK) that are compared against a control population of 905,211 dogs without osteosarcoma taken from primary care electronic patient records in the VetCompass™ dataset. Methods and Study DesignRetrospective, case-control study. Multivariable logistic regression analysis explored associations between demographic risk factors (including breed, chondrodystrophy, age, sex/neuter status, skull-shape, and body mass) and osteosarcoma. ResultsWe identified several breeds with increased and reduced odds of osteosarcoma. At highest risk were the Rottweiler and Great Dane, with >10 times the odds of osteosarcoma compared with crossbreeds, and the Rhodesian Ridgeback; which has not featured in previous lists of at-risk breeds for osteosarcoma, and had an odds ratio of 11.31 (95% confidence interval 7.37 - 17.35). Breeds at lowest risk of osteosarcoma (protected breeds) included the Bichon Frise, the French Bulldog and the Cavalier King Charles Spaniel, all with odd ratios of less than 0.30 compared with crossbreeds. Body mass was strongly associated with osteosarcoma risk; dogs over 40kg exhibited osteosarcoma odds of 45.44 (95% confidence interval 33.74 - 61.20) compared with dogs less than 10kg. Chondrodystrophic breeds had an osteosarcoma odds ratio of 0.13 (95% confidence interval 0.11 - 0.16) compared with non-chondrodystrophic breeds. ConclusionsOverall, this study provides evidence of strong breed-associated osteosarcoma risk and protection, suggesting a genetic basis for osteosarcoma pathogenesis. The study findings highlight that breeds bred for long legs or large body mass are generally overrepresented amongst at-risk breeds, whilst those bred for short leg length or small body mass are generally protected. These findings could inform genetic studies to identify osteosarcoma risk alleles in canines and humans; as well as increasing awareness amongst vets and owners, resulting in improved breeding practices and clinical management of osteosarcoma in dogs.

4 January 2026 in Veterinary and Comparative Orthopaedics and Traumatology
Verified
Journal Article
Closed access
PDF file
CTCatherine Tindale
Catherine Tindale
EDEmma Deards
Emma Deards
KWKate Whybrow
Kate Whybrow
ALAaron Lutchman
Aaron Lutchman
GEGrace Edmunds
Grace Edmunds
SLSorrel L. Langley-Hobbs
Sorrel L. Langley-Hobbs
Diagnosis of cranial cruciate ligament rupture (CCLR) is primarily through physical examination, imaging, and intra-articular assessment. Assessment of sit position where affected dogs abduct and extend the stifle to reduce discomfort has been proposed to aid diagnosis but not evaluated as a diagnostic test. This study aimed to evaluate the relationship between sit position and CCLR and assess the sit test as a diagnostic tool. Dogs with CCLR or hip dysplasia (HD) diagnosis were prospectively recruited and allocated to affected (CCLR) and unaffected (HD and normal stifles) groups. Dogs were recorded sitting and videos reviewed by three European College of Veterinary Surgeons (ECVS) diplomates and three ECVS residents. Sit position was graded normal, abnormal, equivocal, or inconclusive. Interobserver agreement, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy were evaluated. Eighty-three dogs (56 affected, 70 unaffected limbs) met inclusion criteria. The sit test demonstrated 61.5% sensitivity, 81.0% specificity, 71.6% PPV, 73.0% NPV, and 72.5% accuracy for CCLR diagnosis. Moderate interobserver agreement was found (κ = 0.536, p < 0.001). Of dogs with the CCLR, 72.5% were correctly identified; however, 27.0% of dogs with a negative sit test were affected by CCLR. The sit test offers a screening test for CCLR in conscious dogs with greater sensitivity and similar specificity to cranial draw and tibial compression tests. It may be a valuable addition in CCLR diagnosis, particularly for conscious remote evaluation.